THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

CEO leaves Sepracor as merger looms

Adrian Adams’s departure was no surprise, an analyst said. Adrian Adams’s departure was no surprise, an analyst said.
By D.C. Denison
Globe Staff / February 20, 2010

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Marlborough drug company Sepracor Inc. said yesterday that Adrian Adams, its president and chief executive, had resigned. Last year, the company entered into an agreement to be purchased by Dainippon Sumitomo Pharma Co. of Japan for $2.6 billion, and yesterday the company said in a statement that Saburo Hamanaka had been appointed chairman of Sepracor. (Full article: 392 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass